Related references
Note: Only part of the references are listed.Liver Injury in Patients With Cholestatic Liver Disease Treated With Obeticholic Acid
John E. Eaton et al.
HEPATOLOGY (2020)
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis
Maren H. Harms et al.
GUT (2020)
Su1645 MALES GENDER IS ASSOCIATED WITH A HIGH RATE OF DECOMPENSATION AND MORTALITY IN PRIMARY BILIARY CHOLANGITIS WITH WELL COMPENSATED CIRRHOSIS
Binu V. John et al.
GASTROENTEROLOGY (2020)
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
Keith D. Lindor et al.
HEPATOLOGY (2019)
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis
Maren H. Harms et al.
JOURNAL OF HEPATOLOGY (2019)
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response
Carla F. Murillo Perez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era Role of Scoring Systems
Aparna Goel et al.
CLINICS IN LIVER DISEASE (2018)
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score
Marco Carbone et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Validation of Veterans Affairs Electronic Medical Record Smoking Data Among Iraq- and Afghanistan-Era Veterans
Patrick S. Calhoun et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2017)
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
Gideon M. Hirschfield et al.
JOURNAL OF HEPATOLOGY (2017)
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study
Palak J. Trivedi et al.
GUT (2016)
The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis
Marco Carbone et al.
HEPATOLOGY (2016)
Liver Transplantation for Cholestatic Liver Diseases in Adults
Vandana Khungar et al.
CLINICS IN LIVER DISEASE (2016)
Obesity paradox in advanced liver disease: obesity is associated with lower mortality in hospitalized patients with cirrhosis
Raffi Karagozian et al.
LIVER INTERNATIONAL (2016)
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy
Willem J. Lammers et al.
GASTROENTEROLOGY (2015)
Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study
Willem J. Lammers et al.
GASTROENTEROLOGY (2014)
The Natural History of Primary Biliary Cirrhosis
Mohamad H. Imam et al.
SEMINARS IN LIVER DISEASE (2014)
Primary Biliary Cirrhosis is More Severe in Overweight Patients
Mia Hindi et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Application and Validation of a New Histologic Staging and Grading System for Primary Biliary Cirrhosis
Kenichi Harada et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis
Christophe Corpechot et al.
HEPATOLOGY (2012)
Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis
Teru Kumagi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid
Edith M. M. Kuiper et al.
GASTROENTEROLOGY (2009)
Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States
Marion G. Peters et al.
HEPATOLOGY (2007)
AUDIT-C as a brief screen for alcohol misuse in primary care
Katharine A. Bradley et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2007)
Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis
Ayako Suzuki et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: A cross validated retrospective assessment
Claudia O. Zein et al.
HEPATOLOGY (2006)
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid
A Parés et al.
GASTROENTEROLOGY (2006)
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis
RE Poupon et al.
JOURNAL OF HEPATOLOGY (2003)
Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years
M Prince et al.
GASTROENTEROLOGY (2002)
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'
KN Lazaridis et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
